USSTOCK.TODAY
Market Closed
Log in Sign up

United Therapeutics stock price and earnings outlook diverge ahead of Q3 results

Earnings Whispers +1 · ·by G4L

UTHR
UTHR United Therapeutics Corp
$588.61 +1.06%
View chart & analysis →
  1. 1United Therapeutics stock has risen approximately 17% since its last earnings announcement.
  2. 2Wall Street analysts' consensus for Q3 revenue is $783.3 million.
  3. 3United Therapeutics aims to achieve annual revenue of $4 billion by the end of 2027.

So what's the key point?

United Therapeutics stock has risen about 17% since the last earnings announcement. Experts expect this quarter's revenue to be around $783.3 million.

Source Earnings Whispers +1 · View original ↗

Related 3-line summaries

United Therapeutics Q3 Earnings Miss Estimates, Revenue Beats Associated Press +2 · 6d agoLiquidia Corporation reaches $380.7 million settlement with United Therapeutics Corporation Investing.com · Oct 14Liquidia Corp shares surge 44.3% in premarket trading on settlement with United Therapeutics Investing.com +2 · Oct 14
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news